US 8889661
Treatment of lupus nephritis using laquinimod
granted A61KA61K2121/00A61K2300/00
Quick answer
US patent 8889661 (Treatment of lupus nephritis using laquinimod) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Nov 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2121/00, A61K2300/00, A61K31/47, A61K31/4704